{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "sharesOutstanding": 94839800, "bookValue": 0.021, "fiftyDayAverage": 0.0971356, "fiftyDayAverageChange": -0.003535606, "fiftyDayAverageChangePercent": -0.03639866, "twoHundredDayAverage": 0.0650739, "twoHundredDayAverageChange": 0.028526098, "twoHundredDayAverageChangePercent": 0.43836465, "marketCap": 8877005, "priceToBook": 4.457143, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "exchange": "PNK", "shortName": "PSYENCE GROUP INC", "longName": "Psyence Group Inc.", "messageBoardId": "finmb_682094975", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0936, "firstTradeDateMilliseconds": 1654003800000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683228864, "regularMarketDayHigh": 0.0936, "regularMarketDayRange": "0.0936 - 0.0936", "regularMarketDayLow": 0.0936, "regularMarketVolume": 7500, "regularMarketPreviousClose": 0.0936, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.0936, "averageDailyVolume3Month": 408, "averageDailyVolume10Day": 750, "fiftyTwoWeekLowChange": 0.0835, "fiftyTwoWeekLowChangePercent": 8.267327, "fiftyTwoWeekRange": "0.0101 - 0.8921", "fiftyTwoWeekHighChange": -0.7985, "fiftyTwoWeekHighChangePercent": -0.8950791, "fiftyTwoWeekLow": 0.0101, "fiftyTwoWeekHigh": 0.8921, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.04, "displayName": "Psyence", "symbol": "PSYGF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Bay Street", "address2": "P.O. Box 10", "city": "Toronto", "state": "ON", "zip": "M5J 2J1", "country": "Canada", "website": "https://www.psyence.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 48, "title": "Co-Founder & Exec. Chairman", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 110646, "fmt": "110.65k", "longFmt": "110,646"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "title": "CEO & Director", "fiscalYear": 2022, "totalPay": {"raw": 207646, "fmt": "207.65k", "longFmt": "207,646"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law", "age": 50, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Warwick  Corden-Lloyd", "age": 42, "title": "CFO & Corp. Sec.", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 110646, "fmt": "110.65k", "longFmt": "110,646"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mary-Elizabeth  Gifford", "title": "Exec. VP of Public Affairs & Corp. Social Responsibility", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tony  Budden", "title": "Chief Strategy Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Clive  Ward-Able BPharm, M.D.", "title": "Medical Director and Head of R&D and Early Commercialization", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}